Lymphomatous Meningitis From Anaplastic Lymphoma Kinase+ Anaplastic Large T-Cell Lymphoma Treated With Lorlatinib: A Case Report-Reference-Cited by-同舟云学术

Lymphomatous Meningitis From Anaplastic Lymphoma Kinase+ Anaplastic Large T-Cell Lymphoma Treated With Lorlatinib: A Case Report

Published:2022-05 Issue:6 Volume: Page:
ISSN:2473-4284
Container-title:JCO Precision Oncology
language:en
Short-container-title:JCO Precision Oncology

Author:

Mellacheruvu Smitha¹²^ORCID,Sayegh Mark N.¹,Sica R. Alejandro³^ORCID,Cheng Haiying²,Santos-Zabala Maria Laureana⁴^ORCID,Gebrael Jacob H.⁵,Hermanto Ulrich⁶,Rosen Norman L.¹

Affiliation:

1. Department of Hematology and Oncology, St John's Riverside Hospital, Yonkers, NY

2. Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY

3. Division of Hematologic Malignancies, Department of Oncology, Montefiore Medical Center, Bronx, NY

4. Department of Anatomic and Clinical Pathology, St John's Riverside Hospital, Yonkers, NY

5. Department of Radiology, St John's Riverside Hospital, Yonkers, NY

6. Department of Radiation Oncology, Montefiore Yonkers Radiation Oncology, Yonkers, NY

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/PO.21.00250

Reference37 articles.

1. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001

2. Non-Hodgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: A longitudinal analysis of the National Cancer Data Base from 1998 to 2011

3. The 2016 revision of the World Health Organization classification of lymphoid neoplasms

4. Fusion of a Kinase Gene, ALK , to a Nucleolar Protein Gene, NPM , in Non-Hodgkin's Lymphoma

5. ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK)

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Controversies in the Front-Line Treatment of Systemic Peripheral T Cell Lymphomas;Cancers;2022-12-30

2. Crizotinib/lorlatinib;Reactions Weekly;2022-04